MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: alox12    
Morpholino sequence: CTCTGTGGTGTGGTGGTGAAAATCT
Find in Genbank
Target name: alox12
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
CAGACACAGTTACTGTGTGTGCTTAAGGCTGACATGAAAGAAGGAAACTAGGGGTGGCTGAGAAAAAAA ATAAAAAAGTCACAGAGACATAAAAGAGCCAACAAAAAAACTACTGCTGAGAAGAAGAAACACGCATCAG ATTTTCACCACCACACCACAGAGAATAGAGAAGAAGAAAACGATCAATTTCATCACCACACTACTGAGAA AAAGATGGAGTACAAAGTGACAGTGGCCACCGGGACTTCTGAATATTCAGGGACCAATAATTATGTGTAC GTGACTCTGATTGGAGAGAAAGGAAAGAGCGAGAGGACGCTGCTGGACAATCCTGGCCTGGACTTCTGCA GAGGAGCTGTGGATGATTACATAGTTAAAAGCGATACTGATTTGGGCCCCCTGATTCTGGTGCGACTGGA GAAGCACAAGTACTTCATAGAAGACAACTGGTTCTGCCGCTACGTGAAAGTCAGTGTACCTGGAGAAAGA TGTTGTTACACATTTCCTTGTTACCGCTGGCTTGTGGGAGATGGAGTGTTTGTAGAGCTCAGAGAAGGCA CAGCCAAAAAGCTGAGCGAAGACAGTCTGCCGCTGGAAATGGCTCACAGACAATCAGAGCTTCAGGAGAG GCAGAAAACATACAGATGGGTTGCATGGGCTCCTGGCATTCCCAAATGCATTGATGCAAAAAGTGAAGCT GATCTGCCCCAGGACGCTCGATTTGACAACGAGAAACGCAGTGATTTTGAGGGATCTCTTCATTATGCTC TGTTGGAGCTCTCACTGAAAAAATTGGCAATCCGGTTTGGAAAGTCCTGGAGTGACCTGGAGGATTTCAG GAGGATCTTCTGGAAACTAAGAAGCCCCATAGCTGAATACACCATGGAGCACTGGAAAGAAGACTGGTTT TTTGCTTACCAGTTCTTGAACGGCTCAAACCCACGGAATATCACCAGATTGAAAAAGGTGCCTTCAAACT TCCTTGTCACTGGAGATATGGTTCAGTCATCTCTGATACCCACAACCACTCTGAATGAGGAACTCAAGAA AGGAAACATTTTCCTGGTTGATCATGCAATACTGGATGGGATTCCTGCCAATGTAATCAGAAACAGCCCC CAGTATATTGCTGCCCCACTCTGCTTACTGTATGAACACCCTGAGAAAGGGCTCATTCCCATCGCCATAC AGCTTGAACAGAAACCTGATAAGGACACACCCGTATTTCTGCCCAGTGATCCACCTCTGGCCTGGTTGTT GGCTAAGATGTGGGTTCGTCATGCTGAATTCCAGGTCTTTCAGTTGTTGTCTCATCTGCTGCGCACACAT TTGATGGTAGAAGTGATCTGTGTGGCCACACTACGGCAGCTGCCAGCTGTTCACCCCATATATAAGCTCT TGACTCCACACTTGAGGTACACGCTGGAGATTAACTGTCGTGGCAGAACACAGCTCCTCTCTCCAGAGGG CATCTTCAAAAGGGTGGTGTCCACAGGTGGAGAAGGTCTCTTGATATTGGCTCAAAGGGAGTATAAAGTT CTGACCTATCGCTCTCTTCAGCCTAAATTTGACTTCTTGGACAGAGGGGTTACTAAAGTGAAAGGCTATG TTTACAGAGACTACTCTCTGATGCTGTGGGATGTGATTCAGAATTTTGTTTCAGGAATTGTTTCCCTGTA CTACCAGTGTGACAGTGACGTGCAAGAGGACTCTGAGCTTCAGGCCTGGATTCATGATGTGGCTGTGGAA GGCTTTGTGGATGTTCCTGAATTTGGCCTGGCCAGTGATATGAAGACAAAAGAGGAGCTGATCACTCTGT TAAGTGTGGCGATCTTCACCAGCACAGCACAACATGCTGCCACAAACAACGGACAGTTTGACTGGTGCGC TTGGGTACCCAACACCCCCTGCACCATGAGACACCCCCCACCAAGAGATAAAGATGCAGTGACCATGGAA ATGATTATGGACACGCTGCCTGACATCAGCCAGTCCTGTGTGCAGATGGCCATCACATGGCATTTGGGCC GGGCACAGCCTGATGCGATCCCAATGGGCCAGTATGTGGAGCAGTACTTCACTGAACCCGCTGCTTTGAA GGTGATTGACAAATTCAGGAAAGAGCTGAAAGAACTGGAGGACAAGATAATGGCCCAGAACGAGGGACTC GAACTTCAGTACCTTTACCTTTGTCCAAGCCGCATGGAAAACAGCATCACTATTTAGAGACAAAAACATA AACACTACCTGACAAAAGTCGTCGCCTATCCAAGTATTAGGAGCAGCAAATAGTGGCTTGACTTCTGGTT GATCATTTGGTATCAGATGTGGCTTATATGAAAGGCAAAGGCCTCTAGATTACACTTATTTTACCAAAAT AAAACATGATCCTGCCTTGATTTTTAATTGTTTAATTAGGACAGTAAGGTCTGACTTTGCTTGGACAGTC TTGTTGCGTAATGTGCAGAAATAATGTCAAAGAAAGCGTTCTTGCAGGACTCCTCGAATCATCAAGATTC TTTGAATTCATCTTCAATGCCTTCTCCTTCATCTTACCCCAGACATGCTCAATAATGTTCTTATCTGGTG ACTGGGCTGGCCAATCTTGGAGCACCTTGACCTTCTTTGCTTTCAGGAACTTTGTGGAGGCTTAAGTATG AGAAGGAGCGCTATGAAGAATAATAGCACAGAATCTTCTGCCAAATCTACCTTCTGCCACTTTTCCAAAT GATCGATTGGAAGTCAAGTTATTATTTGTTGCTATTACAACTGGGATCGACGGCAATTCTTTTGTCAGGT AGAGTACATGTAAATACGCATTTGTACCATCTTTTCCAGTCAATGACTTGCTCAGCAATGGGATCTATCA CAGCATGTGTCAAAATTGTAATATATATCATTTGAAACTTTGTAAAGCATCAGTACGTAAAGCTTTTTTA TATTCACTTTAGTGAACCGTTTTTTTTAGTTTGATTTTAAACTAATAATGTGCATTGAACTGTTTGAACG GAACTTTCTATGAGCTGTTTCTGTGTATATTTTACCACTGTATGCATCAGCTTTAGAAAACACACGTTTT ATATTTAATACATTTTTGTTTCAGATGCAGACAATGCATCATCACTAAACTTTAATCTGTGTACATATGC ATGCATTGGCTTTTCATTTGTCCATTGCAAATAAAGATTTTTGTTAACACTTTAGGTCACAATTTATTTT ATTAACTACTCGCCTATTACCTGCCTATTATTAAGATATTAACTGTTCATTAGTGGTTATGAAGTATGAT CTTATTCTGCATCCCCAATTCTTCCCTTAAACTAAACTCAACTTCTACCTTACTATGAATAAACAGTTAA TTAGTCGTTCATTAGGGTAGTAGTGTTAGTTAATGGTTTGTTAATATCGTGAAGTATGACCTAAAGTGTC ACCAAACATTTTTATTTCATATTTTAGTGTTGTATTCTTATTTTACTTGTAATATTTTCCTGCATATCTT TATCTGTGGACACCATTCATTAAAAAATTATAAATCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Gene targeted:
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
None

Images